Active BE 0831.344.834Private limited company

DR. BART DECROIX

Koestraat 18 ·8800 Roeselare, Belgium· 15 yrs active

Sector: General medical practice (86210)

Conclusion Checked

The computed 12-month bankruptcy probability of DR. BART DECROIX is 0.1% (very low). The 2024 annual accounts show equity of €785k and a net result of €164k. Equity is growing by ~15.4% per year across the filed fiscal years. Its solvency ranks better than 91% of 6549 sector peers (fiscal year 2024). The company has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 7 annual accounts.

Key figures

Equity	€785k
Net result	€164k
Better than sector	91%
Active	15 yrs

Snowflake analysis 5 axes · computed by Checked

96 / 100

Exceptional profile, strong across almost every axis.

Health 100

Profitability 100

Solvency 100

Growth 78

Stability 100

Bankruptcy probability (12 mo) Checked model v1 · free

0.1% Very low

0%0,5%1,5%4%10%≥25%

Lower-failure-rate sector −Long track record −Annual accounts: healthy financial profile −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based

0 / 100

Low risk

Trust signals 3 signals

Established

Founded in 2010, 15 years in business.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.

Administratively compliant

No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags 0 events

No administrative flags

Health barometer FY 2024 · computed

100 / 100 Excellent

050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →

Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.

Financial overview10 NBB filings

Annual accounts filed on 17-07-2025 with the NBB · fiscal year 2024 · micro

Operating resultNet result

Trajectory (indicative)

Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.

growing Equity: growth of ~15.4%/year over 7 fiscal years, indicative, assuming unchanged policy.

Solid line = filed figures · dashed = extended trend · area = indicative range.

How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison

Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	93.3%	66.7%	better than 91% of 6549 sector peers
Net result	€164k	€46k	better than 90% of 6543 sector peers
Equity	€785k	€79k	better than 95% of 6549 sector peers
Gross operating margin	€249k	€78k	better than 90% of 6551 sector peers
Staff costs	€14k	€21k	higher than 42% of 1203 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

EBITDA

€235k

+4.1% +224% vs sector

Net profit

€164k

+8.8% +235% vs sector

Cash flow

€173k

+9.0% +190% vs sector

Total assets

€841k

+17.1% +150% vs sector

Equity

€785k

+17.4% +193% vs sector

Working capital

€737k

+16.3% +192% vs sector

Employees (FTE)

0

0.0% -78% vs sector

Staff costs

€14k

+8.4% -49% vs sector

Income taxes

€73k

+6.0% far above sector median

Dividends

€47k

+10.9% -62% vs sector

Debt

€56k

+13.3% +71% vs sector

Debt ≤ 1y

€54k

+12.8% +66% vs sector

Current ratio

14.53

+2.8% +130% vs sector

Quick ratio

14.53

+2.8% +130% vs sector

Solvency

93.3%

+0.2% +3% vs sector

Debt / equity

0.07

-3.4% -34% vs sector

ROE

20.8%

-7.3% +38% vs sector

ROA

19.4%

-7.1% +36% vs sector

Interest coverage

195.75

+19.1% +198% vs sector

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2024
Revenue	-
EBITDA	€235k
Net profit	€164k
Cash flow	€173k
Staff costs	€14k
Income taxes	€73k
Dividends	€47k
Total assets	€841k
Equity	€785k
Debt	€56k
of which ≤ 1y	€54k
of which > 1y	-
Working capital	€737k
Employees (FTE)	-

Ratios (computed)

	2024
Current ratio	14.53
Quick ratio	14.53
Working capital ratio	87.6%
Solvency	93.3%
Debt / equity	0.07
Long-term debt ratio	-
Interest coverage	195.75
Gross margin	-
Net margin	-
ROA	19.4%
ROE	20.8%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2024

Assets

Fixed assets €50k · 5.9% Current assets €792k · 94.1%

Equity & liabilities

Equity €785k · 93.3% Debt €56k · 6.7%

Full annual accounts

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€841k
Fixed assets	21/28	€50k
Tangible fixed assets	22/27	€50k
Current assets	29/58	€792k
Amounts receivable within one year	40/41	€80k
Investments	50/53	€447k
Cash & bank	54/58	€263k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€841k
Equity	10/15	€785k
Contributions / capital	10/11	€12k
Reserves	13	€773k
Amounts payable	17/49	€56k
Amounts payable within one year	42/48	€54k
Trade debts payable within one year	44	€319
Income statement
Gross operating margin	9900	€249k
Operating result	9901	€225k
Financial income	75	€13k
Financial charges	65	€1k
Result before taxes	9903	€237k
Income taxes	67/77	€73k
Net result for the period	9904	€164k
Result to be appropriated	9905	€164k

You're seeing the latest fiscal year only. Unlock 4 prior years (figures + ratios) with a paid plan. See plans →

Ratios computed by Checked.

Legal Structure

NACE primary	General medical practice(86210)
Legal form	Private limited company(610)
Incorporation	22-11-2010
Status	Active
Postal code	8800

Establishment units 1 location

Koestraat 18, 8800 Roeselare

Activiteiten van huisartspraktijken

since 20112.194.899.568

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
36302B0957/00F000	Flanders	1,768 m²	1 · 328 m²	8.5 m · 2 fl.

Methodology

via registered seat: 1

1 of 1 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Updates 10 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2025

17-07-2025